• 1
    NIH consensus conference. Treatment of early-stage breast cancer. JAMA. 1991; 265: 391-395.
  • 2
    Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347: 1233-1241.
  • 3
    Sarrazin D, Le MG, Arriagada R, et al. Ten-year results of a randomized trial comparing conservative treatment to mastectomy in early breast cancer. Radiother Oncol. 1989; 14: 177-184.
  • 4
    Veronesi U. Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 2001; 12: 997-1003.
  • 5
    Liljegren G, Holmberg L, Bergh J, et al. Ten-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol. 1999; 17: 2326-2333.
  • 6
    Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer, N Engl J Med. 2004; 351: 963-970.
  • 7
    Malmstrom P, Holmberg L, Anderson H, et al. Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening, Eur J Cancer. 2003; 39: 1690-1697.
  • 8
    Winzer KJ, Sauer R, Sauerbrei W, et al. Radiation therapy after breast-conserving surgery: first results of a randomised clinical trial in patients with low risk of recurrence. Eur J Cancer. 2004; 40: 998-1005.
  • 9
    Holli K, Saaristo R, Isola J, et al. Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study, Br J Cancer. 2001; 84: 164-169.
  • 10
    Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366: 2087-2106.
  • 11
    Nattinger AB, Hoffmann RG, Kneusel RT, Schapira MM. Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. Lancet. 2000; 356: 1148-1153.
  • 12
    Lazovich D, Solomon CC, Thomas DB, Moe RE, White E. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer. 1999; 86: 628-637.
  • 13
    Freedman RA, He Y, Winer EP, Keating NL. Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol. 2009; 27: 713-719.
  • 14
    Surveillance, Epidemiology, and End Results (SEER) Program. SEER limited-use data (1973-2004) [released April 15, 2010]. Bethesda, MD: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2010. Available at: [Accessed April 11, 2011].
  • 15
    Agresti A. Categorical Data Analysis. New York, NY: John Wiley & Sons, Inc.; 1990.
  • 16
    Taylor CW, McGale P, Darby SC. Cardiac risks of breast-cancer radiotherapy: a contemporary view. Clin Oncol (R Coll Radiol). 2006; 18: 236-246.
  • 17
    Mandelblatt JS, Kerner JF, Hadley J, et al. Variations in breast carcinoma treatment in older Medicare beneficiaries: is it black or white. Cancer. 2002; 95: 1401-1414.
  • 18
    Yood MU, Owusu C, Buist DS, et al. Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg. 2008; 206: 66-75.
  • 19
    Shavers VL, Harlan LC, Stevens JL. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer. 2003; 97: 134-147.
  • 20
    Joslyn SA. Racial differences in treatment and survival from early-stage breast carcinoma. Cancer. 2002; 95: 1759-1766.
  • 21
    Vinh-Hung V, Voordeckers M, Van de Steene J, Soete G, Lamote J, Storme G. Omission of radiotherapy after breast-conserving surgery: survival impact and time trends. Radiother Oncol. 2003; 67: 147-158.
  • 22
    Smith BD, Smith GL, Roberts KB, Buchholz TA. Baseline utilization of breast radiotherapy before institution of the Medicare Practice Quality Reporting Initiative. Int J Radiat Oncol Biol Phys. 2009; 74: 1506-1512.
  • 23
    Chagpar AB, McMasters KM, Scoggins CR, et al. The use of radiation therapy after breast-conserving surgery in hormonally treated breast cancer patients is dependent on patient age, geographic region, and surgeon specialty. Am J Surg. 2008; 195: 793-798.
  • 24
    Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med. 1992; 326: 1097-1101.
  • 25
    Nattinger AB, Kneusel RT, Hoffmann RG, Gilligan MA. Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst. 2001; 93: 1344-1346.
  • 26
    Sanghani M, Truong PT, Raad RA, et al. Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy. J Clin Oncol. 2010; 28: 718-722.
  • 27
    Bickell NA, Shastri K, Fei K, et al. A tracking and feedback registry to reduce racial disparities in breast cancer care. J Natl Cancer Inst. 2008; 100: 1717-1723.
  • 28
    Abbott AM, Habermann EB, Tuttle TM. Trends in the use of implantable accelerated partial breast irradiation for early stage breast cancer in the United States. Cancer. 2011; 117: 3305-3310.
  • 29
    Vaidya JS, Joseph DJ, Tobias JS, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet. 2010; 376: 91-102.
  • 30
    Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010; 362: 513-520.